These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3875056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR.
    Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
    Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR.
    Brain Res; 1990 Oct 29; 531(1-2):95-104. PubMed ID: 2289139
    [Abstract] [Full Text] [Related]

  • 5. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
    Mitchell IJ, Boyce S, Sambrook MA, Crossman AR.
    Brain; 1992 Jun 29; 115 ( Pt 3)():809-24. PubMed ID: 1628204
    [Abstract] [Full Text] [Related]

  • 6. Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus.
    Mitchell IJ, Sambrook MA, Crossman AR.
    Brain; 1985 Jun 29; 108 ( Pt 2)():405-22. PubMed ID: 4005529
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cerebral metabolism of parkinsonian primates 21 days after MPTP.
    Schwartzman RJ, Alexander GM, Ferraro TN, Grothusen JR, Stahl SM.
    Exp Neurol; 1988 Dec 29; 102(3):307-13. PubMed ID: 3264247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
    Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR.
    Neurosci Lett; 1985 Oct 24; 61(1-2):195-200. PubMed ID: 3878482
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity.
    Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    J Neural Transm Gen Sect; 1995 Oct 24; 101(1-3):65-82. PubMed ID: 8695058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
    Schwartzman RJ, Alexander GM.
    Brain Res; 1985 Dec 09; 358(1-2):137-43. PubMed ID: 3878182
    [Abstract] [Full Text] [Related]

  • 17. Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates.
    Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, Kopin IJ, Sokoloff L.
    Brain Res; 1988 Jun 21; 453(1-2):227-34. PubMed ID: 3261197
    [Abstract] [Full Text] [Related]

  • 18. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bédard PJ, Di Paolo T.
    Brain Res; 1995 May 22; 680(1-2):43-52. PubMed ID: 7663983
    [Abstract] [Full Text] [Related]

  • 19. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Exp Neurol; 2000 May 22; 163(1):191-9. PubMed ID: 10785458
    [Abstract] [Full Text] [Related]

  • 20. Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease.
    Schwartzman RJ, Alexander GM.
    Adv Neurol; 1987 May 22; 45():171-3. PubMed ID: 3493624
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.